Nexlizet
Active Ingredient(s): Bempedoic Acid + EzetimibeFDA Approved: * February 26, 2020
Pharm Company: * ESPERION THERAPS INC
Category: Cholesterol
Bempedoic acid/ezetimibe, sold under the brand name Nexlizet among others, is a fixed-dose combination medication used for the treatment of high cholesterol.[1][3] It is a combination of bempedoic acid and ezetimibe.[1][2] The most common side effects are hyperuricemia (high blood levels of uric acid) and constipation.[2] Bempedoic acid is an adenosine triphosphate-citrate lyase (ACL) inhibitor and ezetimibe is a ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.